Stemina Biomarker Discovery
BioTech/Drugs - Madison, WI, US
Stemina Biomarker Discovery Employees
Stemina Biomarker Discovery Senior Management
Stemina Biomarker Discovery Details
Stemina Biomarker Discovery is a metabolomics company focused on the discovery, development, and commercialization of molecular biomarkers to improve drug safety and human health. Stemina's cell based assays arise from the strategic convergence of two cutting edge technologies: human embryonic stem (hES) cells and metabolomics. Stemina uses mass spectrometry to analyze the small molecules secreted by hES cells, and differentiated cells such as heart and neural cells made from hES cells, in response to drugs, injury or disease. Stemina opened its state-of-the-art facilities for hES cell culture and mass spectrometry in the UW Research Park in Madison Wisconsin on November 1, 2007.
Stemina Biomarker Discovery Technologies
Email Providers
Outlook
CMS
WordPress.org
Fonts
Google Font API
Analytics and Tracking
Google Analytics
Other
Mobile Friendly